140 related articles for article (PubMed ID: 34389420)
1. Gas generating microspheres for immediate release of Hsp90 inhibitor aiming at postembolization hypoxia in transarterial chemoembolization therapy of hepatocellular carcinoma.
Choi JW; Lee SY; Cho EJ; Jeong DI; Kim DD; Kim HC; Cho HJ
Int J Pharm; 2021 Sep; 607():120988. PubMed ID: 34389420
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor.
Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ
Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic targeting and activating TH-302 loaded transcatheter arterial embolization microsphere.
Ma P; Chen J; Qu H; Li Y; Li X; Tang X; Song Z; Xin H; Zhang J; Nai J; Li Z; Wang Z
Drug Deliv; 2020 Dec; 27(1):1412-1424. PubMed ID: 33096947
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
[TBL] [Abstract][Full Text] [Related]
5. Monodisperse CaCO
Chen M; Guo X; Shen L; Ding J; Yu J; Chen X; Wu F; Tu J; Zhao Z; Nakajima M; Song J; Shu G; Ji J
Int J Biol Macromol; 2023 Mar; 231():123160. PubMed ID: 36610575
[TBL] [Abstract][Full Text] [Related]
6. Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma.
Wang GZ; Fang ZT; Zhang W; Qu XD; Qian S; Liu R; Wang JH
Oncol Rep; 2014 Jan; 31(1):95-102. PubMed ID: 24173823
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
8. HIF-2α-targeted interventional chemoembolization multifunctional microspheres for effective elimination of hepatocellular carcinoma.
Chen M; Shu G; Lv X; Xu X; Lu C; Qiao E; Fang S; Shen L; Zhang N; Wang J; Chen C; Song J; Liu Z; Du Y; Ji J
Biomaterials; 2022 May; 284():121512. PubMed ID: 35405577
[TBL] [Abstract][Full Text] [Related]
9. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.
Luz JH; Luz PM; Martin HS; Gouveia HR; Levigard RB; Nogueira FD; Rodrigues BC; de Miranda TN; Mamede MH
Cancer Imaging; 2017 Feb; 17(1):5. PubMed ID: 28166821
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable poly(lactide-co-glycolide) microspheres encapsulating hydrophobic contrast agents for transarterial chemoembolization.
Jeon SI; Kim MS; Kim HJ; Kim YI; Jae HJ; Ahn CH
J Biomater Sci Polym Ed; 2022 Mar; 33(4):409-425. PubMed ID: 34613885
[TBL] [Abstract][Full Text] [Related]
11. Drug-Eluting Porous Embolic Microspheres for Trans-Arterial Delivery of Dual Synergistic Anticancer Therapy for the Treatment of Liver Cancer.
Amoyav B; Bloom AI; Goldstein Y; Miller R; Sharam M; Fluksman A; Benny O
Adv Healthc Mater; 2023 Dec; 12(30):e2301548. PubMed ID: 37315950
[TBL] [Abstract][Full Text] [Related]
12. Preparation of microspheres encapsulating sorafenib and catalase and their application in rabbit VX2 liver tumor.
Li X; Yu H; Huang Y; Chen Y; Wang J; Xu L; Zhang F; Zhuge Y; Zou X
Biomed Pharmacother; 2020 Sep; 129():110512. PubMed ID: 32768982
[TBL] [Abstract][Full Text] [Related]
13. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis.
Ni JY; Xu LF; Wang WD; Sun HL; Chen YT
World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037
[TBL] [Abstract][Full Text] [Related]
14. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK
AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514
[No Abstract] [Full Text] [Related]
15. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
16. Batimastat nanoparticles associated with transcatheter arterial chemoembolization decrease hepatocellular carcinoma recurrence.
Xiao L; Wang M
Cell Biochem Biophys; 2014 Sep; 70(1):269-72. PubMed ID: 24639109
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Microspheres Dual-Loaded with Doxorubicin and Sodium Bicarbonate Nanoparticles to Introduce Synergistic Trimodal Interventional Therapy.
Chen M; Xu X; Shu G; Lu C; Wu J; Lv X; Song J; Wu F; Chen C; Zhang N; Du Y; Wang J; Xu M; Fang S; Weng Q; Zhu Y; Huang Y; Zhao Z; Du Y; Ji J
ACS Appl Bio Mater; 2021 Apr; 4(4):3476-3489. PubMed ID: 35014432
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor.
Choi JW; Park JH; Cho HR; Chung JW; Kim DD; Kim HC; Cho HJ
Sci Rep; 2017 Apr; 7(1):554. PubMed ID: 28373713
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinoma.
Liu YS; Ou MC; Tsai YS; Lin XZ; Wang CK; Tsai HM; Chuang MT
Korean J Radiol; 2015; 16(1):125-32. PubMed ID: 25598680
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Treatment Response and Survival Profiles Between Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Chinese Hepatocellular Carcinoma Patients: A Prospective Cohort Study.
Wen P; Chen SD; Wang JR; Zeng YH
Oncol Res; 2019 May; 27(5):583-592. PubMed ID: 31053181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
